Summary of all mutations in the cytoplasmic C terminus of FliF and of the corresponding phenotypic analysis described in this study. (A) A schematic diagram of the last 30 amino acids of the C terminus is shown on the left. The shaded areas are the two regions that were proposed to form α-helices by the secondary-structure prediction program PDHsec. The area between the two predicted α-helices is referred to as the loop region in the text. The corresponding mutant names are on the left. Flagellar assembly: flagella detected by electron microscopy (see Fig. 6). A plus indicates that most of the swarmer cells were flagellated, a minus indicates that no swarmer cells were flagellated, and a minus in parentheses indicates that very few swarmer cells were flagellated. Motility: cell motility determined by light microscopy. A plus indicates that swimming cells were observed, and a minus indicates that no swimming cells were present. Swarmer colony formation: motility assayed on semisolid agar plates. A plus indicates formation of a large swarmer colony of wild-type size, a minus indicates a small, compact colony, and a plus in parentheses indicates a swarmer colony of intermediate size (see Fig. 2 and 4). Filamentous morphology: cell morphology determined by light microscopy (see Fig. 5). A plus indicates that the cells were filamentous, and a minus indicates that the cells had wild-type morphology. Class III expression: activity of the flgF flagellar class III promoter (see Fig. 7). A plus indicates wild-type promoter activity, a minus indicates background promoter activity, and a plus-and-minus sign indicates intermediate promoter activity. Motile suppressors: isolation of motile suppressors from nonmotile mutants. A plus indicates that motile suppressors could be isolated, and a minus indicates that no motile suppressors were found. The numbers in parentheses are the numbers of independent suppressor strains isolated. Abbreviations: ND, not determined; NA, not applicable. (B) Immunoblot analysis of strains expressing FliF mutant forms using an anti-FliF antibody. Extracts (normalized for cell numbers) of the following strains were used: lane 1, LS1218 (ΔfliF); lane 2, NA1000 (wild type); lane 3, LS1528 (wild-type fliF); lane 4, UJ556 (fliF Δ9); lane 5, UJ857 (fliF Δ10); lane 6, UJ970 (fliF Δ13); lane 7, UJ971 (fliF Δ14); lane 8, UJ974 (fliF S3); lane 9, LS1218 (ΔfliF); lane 10, NA1000 (wild type); lane 11, UJ358 (fliF ΔIV); lane 12, UJ359 (fliF ΔV); lane 13, UJ553 (fliF Δ6); lane 14, UJ434 (fliF Δ5); lane 15, UJ554 (fliF Δ7); lane 16, UJ555 (fliF Δ8).